KN
INSIDER · BBIO · BridgeBio Pharma, Inc. · CHIEF EXECUTIVE OFFICER
Kumar Neil
Every open-market transaction filed under this name, Aug 18 to Sep 17.
Filings
9
0 buys · 9 sells
Bought
—
open market, at cost
Sold
$4.4M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 17 | BBIO | BridgeBio Pharma, Inc. | Chief Executive Officer | Sell | 1,279 | $69.57 | $89K | — |
| Sep 17 | BBIO | BridgeBio Pharma, Inc. | Chief Executive Officer | Sell | 8,721 | $69.01 | $602K | — |
| Aug 19 | BBIO | BridgeBio Pharma, Inc. | Chief Executive Officer | Sell | 100 | $85.65 | $9K | — |
| Aug 19 | BBIO | BridgeBio Pharma, Inc. | Chief Executive Officer | Sell | 1,800 | $84.69 | $152K | — |
| Aug 19 | BBIO | BridgeBio Pharma, Inc. | Chief Executive Officer | Sell | 8,100 | $83.86 | $679K | — |
| Aug 18 | BBIO | BridgeBio Pharma, Inc. | Chief Executive Officer | Sell | 1,199 | $83.77 | $100K | — |
| Aug 18 | BBIO | BridgeBio Pharma, Inc. | Chief Executive Officer | Sell | 14,602 | $82.99 | $1.2M | — |
| Aug 18 | BBIO | BridgeBio Pharma, Inc. | Chief Executive Officer | Sell | 17,279 | $82.21 | $1.4M | — |
| Aug 18 | BBIO | BridgeBio Pharma, Inc. | Chief Executive Officer | Sell | 1,900 | $81.15 | $154K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.